RGRohit Gunan Ganju
Rohit Gunan Ganju
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rohit Gunan Ganju has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Mindi TenNapel
Department of Radiation Oncology, University of Kansas Medical Center, United States
2 shared publicationsAmir Zahra
Department of Radiation Oncology, University of Kansas Cancer Center, Kansas University Medical Center, Kansas City, KS, USA
1 shared publication- Andres M. Bur
Department of Otolaryngology – Head and Neck Surgery University of Kansas Medical Center Kansas City Kansas USA
1 shared publication Andrew Hoover
Department of Radiation Oncology, University of Kansas Medical Center, United States
1 shared publication- Andrew Hoover
Department of Radiation Oncology, University of Kansas Cancer Center, Kansas University Medical Center, Kansas City, Kansas, USA
1 shared publication - Christopher E. Lominska
Radiation Oncology
1 shared publication
Latest Publications
- Open Access
- 1 September 2019
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 105 (1) , E420
Skeletal Muscle Gauge Measured at the C3 Vertebral Body Predicts for Outcomes in Men with P16-Positive Oropharynx Cancer
- 1 September 2019
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 105 (1) , E420
Open AccessSkeletal Muscle Gauge Measured at the C3 Vertebral Body Predicts for Outcomes in Men with P16-Positive Oropharynx Cancer
- 1 August 2019
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 137, 117-124
The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation
- 1 August 2019
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 137, 117-124
The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation
- Open Access
- 9 January 2018
- Published by Wiley in Journal of Oncology
- Vol. 2018, 1-7
The Efficacy of Conventionally Fractionated Radiation in the Management of Osseous Metastases from Metastatic Renal Cell Carcinoma
Background. There is little data regarding the effectiveness of palliative radiation with conventional fractionation for metastatic renal cell carcinoma (RCC), which has been described as radioresistant. We conducted a retrospective analysis of patients with metastatic bony disease from RCC treated with radiation therapy at our institution. Methods. Forty patients with histologically confirmed RCC with a total of 53 treatment courses were included. Pain response after radiotherapy was recorded and freedom from progression was generated using posttreatment radiographs. Patient data was analyzed to assess influence on local control. Results. Patients had a median age of 63. Median follow-up was 9.3 months. The most common radiation dose was 30 Gy in 10 fractions. Pain control after radiotherapy was achieved in 73.6% of patients. Increasing age was associated with nonresponse at the initial pain assessment post-RT . In lesions with initial pain response, nonclear cell histology was associated with increased pain recurrence and a shorter duration to pain recurrence . Radiographic control at 1 year was 62%. Conclusions. Pain response and control rates for osseous metastatic disease in RCC are comparable to other histologies when treated with conventional fractionation. These appear to be inferior to reported control rates from stereotactic treatments.- 9 January 2018
- Published by Wiley in Journal of Oncology
- Vol. 2018, 1-7
Open AccessThe Efficacy of Conventionally Fractionated Radiation in the Management of Osseous Metastases from Metastatic Renal Cell Carcinoma
Background. There is little data regarding the effectiveness of palliative radiation with conventional fractionation for metastatic renal cell carcinoma (RCC), which has been described as radioresistant. We conducted a retrospective analysis of patients with metastatic bony disease from RCC treated with radiation therapy at our institution. Methods. Forty patients with histologically confirmed RCC with a total of 53 treatment courses were included. Pain response after radiotherapy was recorded and freedom from progression was generated using posttreatment radiographs. Patient data was analyzed to assess influence on local control. Results. Patients had a median age of 63. Median follow-up was 9.3 months. The most common radiation dose was 30 Gy in 10 fractions. Pain control after radiotherapy was achieved in 73.6% of patients. Increasing age was associated with nonresponse at the initial pain assessment post-RT . In lesions with initial pain response, nonclear cell histology was associated with increased pain recurrence and a shorter duration to pain recurrence . Radiographic control at 1 year was 62%. Conclusions. Pain response and control rates for osseous metastatic disease in RCC are comparable to other histologies when treated with conventional fractionation. These appear to be inferior to reported control rates from stereotactic treatments.